Category Archives: Depakote

Featured Stories

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

$15 Million in Damages Awarded to Child for Birth Defects Linked to Depakote

$15M Awarded to Child for Defects Linked to Depakote

This week a St. Louis jury found that a Minnesota girl’s birth defects were caused by the epilepsy medication Depakote her mother took during pregnancy and the jury awarded the child $15 million in damages. The jury returned the unanimous … Continue reading

Posted in Birth Defects, Depakote, Legal News, Pharmaceuticals | Tagged , , , , |

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

British Health Agency Strengthens Warnings about Valproate

The Medicines and Healthcare Products Regulatory Agency (MHRA), Britain’s drug regulatory agency, has issued a statement urging healthcare professionals to give women better information on the risk of birth defects when Depakote and other valproate medicines are used during pregnancy. … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Epilepsy Medications Tied to Additional Fetal Risks

epilepsy_medications_fetal_risks

An emerging study has found that anti-epileptic drugs—AEDs—contain additional risks to developing fetuses to those on current drug product labeling. AEDs include the brands Tegretol, Carbatrol, Equetro, Epitol, Lomotrigine, and Depakote. The active ingredient in Depakote is valproate. The Danish … Continue reading

Posted in Depakote, Pharmaceuticals |

Study: Reducing Valproate Dose Could Help Minimize Some, Not All, Birth Defects

valporate_specific_birth_defects

Valproate-containing epilepsy drugs have long been linked to serious adverse health effects, including risks of babies being born with birth defects. Depakote is a valproate-containing medication. For instance, while use of epilepsy medications during pregnancy has been associated with congenital … Continue reading

Posted in Depakote, Pharmaceuticals |

Abbott Labs Accused of Racketeering in Depakote Marketing

abbott_acused_of_racketeering

A federal court complaint filed in U.S. District Court in Chicago alleges that Abbott Laboratories engaged in racketeering when it marketed the epilepsy drug Depakote (divalproex) for unapproved uses. The plaintiffs—the Sidney Hillman Health Center of Rochester, New York; the … Continue reading

Posted in Depakote, Pharmaceuticals |

Judge Rules Abbott Can be Sued for Off-label Depakote Sales

Depakote_Off_Label_Sales

U.S. District Judge Virginia Kendall recently upheld a shareholder derivative complaint against Abbott Laboratories for its off-label marketing of the drug Depakote. Physicians are allowed to prescribe drugs for off-label uses, but drug companies are not permitted to market drugs … Continue reading

Posted in Birth Defects, Depakote, Health Concerns, Legal News, Pharmaceuticals |

FDA: Migraine Medication, Depakote, May Lower IQ Scores in Children

Depakote_Lower_IQ

United States regulators are warning pregnant women who also suffer from migraine headaches that Depakote may lower a child’s IQ score by eight to 11 points. Depakote is being changed from a Category D to a Category X drug classification. … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA Warns Pregnant Women: Do Not Take Valproate Containing Migraine Prevention Drugs During Pregnancy

Valproate_Pregnancy_FDA-Warning

The U.S. Food and Drug Administration (FDA) has issued a warning to pregnant women against using valproate sodium products, prescribed for migraine prevention, over risks to their unborn babies. Valproate products include Depacon (valproate sodium); Depakote, Depakote CP, and Depakote … Continue reading

Posted in Depakote, Pharmaceuticals |

FDA: Seizure Drug, Potiga, Associated with Vision Loss, Blue Skin

Anti-seizure medication, Potiga, co-marketed by GlaxoSmithKline Plc and Valeant Pharmaceuticals, may lead to optical and skin problems, the U.S. Food and Drug Administration (FDA) has said. Potiga, which was developed by Valeant, may cause skin to turn blue around the … Continue reading

Posted in Depakote, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.